Seeking Alpha
Value, growth, long-term horizon, medium-term horizon
Profile| Send Message|
( followers)  

Wish you could get an inside peek at your favorite companies? One idea is to consider insider buying trends. With this idea in mind, we ran a screen.

We began by screening the healthcare sector for stocks with high growth projections, with 5-year projected EPS growth rates above 15%.

We then screened these names for those with the confidence of their company insiders, such as members of the board and upper management, with significant net insider purchases over the last six months representing at least 2% of share float. Since most companies only have a handful of company insiders, net insider purchases representing 2% of share float is a big show of confidence in their employer's prospects.

(click to enlarge)

Tool provided by Kapitall.

Do you think these stocks will meet their high growth expectations? Use this list as a starting point for your own analysis.

List sorted by net insider purchases as a percent of share float.

1. Horizon Pharma, Inc. (NASDAQ:HZNP): Develops and commercializes medicines for the treatment of arthritis, pain, and inflammatory diseases. Market cap at $128.4M, most recent closing price at $3.81. 5-year projected EPS growth at 20.00%. Over the last six months, insiders were net buyers of 4,270,210 shares, which represents about 16.85% of the company's 25.35M share float.

2. China Biologic Products, Inc. (NASDAQ:CBPO): Engages in the research, development, manufacturing, and sale of plasma-based pharmaceutical products. Market cap at $222.72M, most recent closing price at $8.70. 5-year projected EPS growth at 30.00%. Over the last six months, insiders were net buyers of 802,860 shares, which represents about 11.6% of the company's 6.92M share float.

3. Amyris, Inc. (NASDAQ:AMRS): An integrated renewable products company, offers renewable compounds for a variety of markets. Market cap at $143.05M, most recent closing price at $2.54. 5-year projected EPS growth at 21.00%. Over the last six months, insiders were net buyers of 2,288,360 shares, which represents about 11.09% of the company's 20.64M share float.

4. Genomic Health Inc. (NASDAQ:GHDX): Focuses on the development and global commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions. Market cap at $988.04M, most recent closing price at $32.88. 5-year projected EPS growth at 42.67%. Over the last six months, insiders were net buyers of 2,890,046 shares, which represents about 10.43% of the company's 27.72M share float.

5. Incyte Corporation (NASDAQ:INCY): Focuses on the discovery and development of proprietary small molecule drugs for hematologic and oncology indications, and inflammatory and autoimmune diseases. Market cap at $2.63B, most recent closing price at $20.52. 5-year projected EPS growth at 25.00%. Over the last six months, insiders were net buyers of 4,585,074 shares, which represents about 3.62% of the company's 126.56M share float.

6. Sunrise Senior Living Inc. (SRZ): Provides senior living services in the United States, Canada, the United Kingdom, and Germany. Market cap at $330.52M, most recent closing price at $5.68. 5-year projected EPS growth at 18.00%. Over the last six months, insiders were net buyers of 1,382,150 shares, which represents about 3.44% of the company's 40.15M share float.

7. Palomar Medical Technologies Inc. (NASDAQ:PMTI): Designs, manufactures, markets, and sells lasers and other light-based products, and related disposable items and accessories for use in dermatology and cosmetic procedures. Market cap at $156.04M, most recent closing price at $7.99. 5-year projected EPS growth at 34.00%. Over the last six months, insiders were net buyers of 378,606 shares, which represents about 2.51% of the company's 15.06M share float.

*Insider data sourced from Yahoo! Finance, all other data sourced from Finviz.

Source: 7 High-Growth Healthcare Small Caps Being Bought Up By Insiders